ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable
The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causing the ongoing coronavirus disease 2019 (COVID-19) pandemic has raised serious concern for patients with chronic...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Thomas H. Brannagan III, Michaela Auer-Grumbach, John L. Berk, Chiara Briani, Vera Bril, Teresa Coelho, Thibaud Damy, Angela Dispenzieri, Brian M. Drachman, Nowell Fine, Hanna K. Gaggin, Morie Gertz, Julian D. Gillmore, Esther Gonzalez, Mazen Hanna, David Tags: Position statement Source Type: research
More News: Amyloidosis | Coronavirus | COVID-19 | Internal Medicine | Pandemics | Rare Diseases | Respiratory Medicine | SARS